Herbalife International
November 2, 2026
LOS ANGELES, California - November 2, 2026
Herbalife reported third-quarter 2026 net sales of $1.35 billion on November 2, up 6.0 percent from $1.27 billion a year earlier and ahead of the company's own guidance range. It was the nutrition company's fifth consecutive quarter of year-over-year sales growth.
On a constant-currency basis, sales rose 7.6 percent, with foreign exchange trimming about 1.6 percentage points from reported growth. Herbalife said the gain came mainly from higher sales volume, and management said worldwide volume rose 8.6 percent during the quarter.
Asia Pacific again led the way. Sales in the region climbed 18.4 percent to $517.9 million, or 26.1 percent in local currencies, driven largely by India, where management said local-currency sales jumped 52 percent. Latin America rose 9.0 percent to $250.2 million. North America, Herbalife's home market, grew 1.7 percent to $267.5 million, its second straight quarter of year-over-year growth. EMEA fell 4.9 percent to $259.0 million, and China dropped 22.0 percent to $55.6 million, or 26.4 percent in local currency.
Net income attributable to Herbalife was $58.8 million, or $0.55 per diluted share, compared with $43.2 million, or $0.42 per share, in the third quarter of 2025. Adjusted earnings were $0.64 per share. Adjusted EBITDA came to $182.4 million, above the company's guidance of $160 million to $180 million, for a margin of 13.5 percent. Gross margin slipped to 77.3 percent from 77.7 percent, which the company attributed to sales mix and cost changes tied to self-manufacturing and sourcing, partly offset by price increases.
The company's April refinancing cut net interest expense by $19.1 million from a year earlier. Herbalife ended the quarter with $409.2 million in cash, about $2.0 billion in total debt and a net leverage ratio of 2.0 times, down from 2.2 times at the end of June. Operating cash flow reached $298.0 million for the first nine months of the year, up from $235.0 million. Herbalife said it will begin buying back stock in the fourth quarter under the $250 million, three-year repurchase program its board authorized in September. No shares were repurchased under that program during the third quarter.
For the full year, Herbalife raised its net sales outlook to growth of 4.9 to 5.9 percent on a reported basis. It kept its reported adjusted EBITDA guidance at $670 million to $690 million and raised the constant-currency figure to $700 million to $720 million. For the fourth quarter, the company expects reported net sales growth of 0.5 to 4.5 percent and adjusted EBITDA of $145 million to $165 million.
The results were the first released under new leadership. John DeSimone, previously chief financial officer, became interim CEO on November 1 following the departure of Stephan Gratziani, and Scott Schaefer moved into the CFO role on the same day, two months earlier than originally planned. A board committee working with an executive search firm is still looking for a permanent chief executive. "Our priorities are clear: disciplined execution, profitable growth, and a focused roadmap for our business opportunity and digital platforms with measurable success metrics," DeSimone said.
In its quarterly report filed the same day, Herbalife disclosed that it reached a confidential settlement on October 2 resolving its long-running lawsuit with former technology vendor Eastern Computer Exchange, an amount the company called not material. The filing also notes that a proposed California class action alleging that Herbalife misclassified distributors as independent contractors remains pending, and that the company does not believe a loss is probable in that case.
Herbalife, founded in 1980, sells weight-management and nutrition products through independent distributors in more than 90 markets.